Literature DB >> 8389529

Reduced nm 23-H1 messenger RNA expression in metastatic lymph nodes from patients with papillary carcinoma of the thyroid.

T Arai1, M Watanabe, M Onodera, T Yamashita, A Masunaga, S Itoyama, K Itoh, I Sugawara.   

Abstract

The nm 23 gene product, which possesses nucleoside diphosphate kinase activity, is a possible mediator of cancer cell invasion and metastasis. It has been divided into two distinct gene products, nm23-H1 and nm23-H2. We have developed a method for detecting nm 23-H1 and nm 23-H2 RNA using the polymerase chain reaction, based on the amplification of complementary DNA copies of nm 23-H1 and nm 23-H2 RNA. Using this method, the nm 23-H1 and nm 23-H2 messenger (m)RNA levels in 35 thyroid papillary carcinomas, 11 metastatic lymph nodes from patients with thyroid papillary carcinomas, five thyroid follicular adenomas, and three normal thyroid tissue samples were studied. Both nm 23-H1 and nm 23-H2 mRNA were expressed ubiquitously in normal and malignant thyroid tissues. However, in metastatic lymph nodes no (3 of 11) or weak expression (8 of 11) of nm 23-H1 mRNA was observed, the extent of which was inversely proportional to the degree of cancer cell occupancy, whereas nm 23-H2 mRNA was expressed and the levels were similar to those in other tissue tested. These results show that nm 23-H1 only may play a role in cancer cell invasion and metastasis although the exact mechanisms involved have yet to be elucidated.

Entities:  

Mesh:

Substances:

Year:  1993        PMID: 8389529      PMCID: PMC1886999     

Source DB:  PubMed          Journal:  Am J Pathol        ISSN: 0002-9440            Impact factor:   4.307


  29 in total

1.  A non-radioactive automated method for DNA sequence determination.

Authors:  W Ansorge; B S Sproat; J Stegemann; C Schwager
Journal:  J Biochem Biophys Methods       Date:  1986-12

2.  The biology of cancer metastasis and implications for therapy.

Authors:  I J Fidler; C M Balch
Journal:  Curr Probl Surg       Date:  1987-03       Impact factor: 1.909

3.  Reduced tumor incidence, metastatic potential, and cytokine responsiveness of nm23-transfected melanoma cells.

Authors:  A Leone; U Flatow; C R King; M A Sandeen; I M Margulies; L A Liotta; P S Steeg
Journal:  Cell       Date:  1991-04-05       Impact factor: 41.582

Review 4.  Cancer metastasis: experimental approaches, theoretical concepts, and impacts for treatment strategies.

Authors:  V Schirrmacher
Journal:  Adv Cancer Res       Date:  1985       Impact factor: 6.242

Review 5.  Tenascin in tissue perturbation repair.

Authors:  T Sakakura; I Kusano
Journal:  Acta Pathol Jpn       Date:  1991-04

6.  Induction of nm23 gene expression in human colonic neoplasms and equal expression in colon tumors of high and low metastatic potential.

Authors:  M Haut; P S Steeg; J K Willson; S D Markowitz
Journal:  J Natl Cancer Inst       Date:  1991-05-15       Impact factor: 13.506

Review 7.  Tumor cell instability, diversification, and progression to the metastatic phenotype: from oncogene to oncofetal expression.

Authors:  G L Nicolson
Journal:  Cancer Res       Date:  1987-03-15       Impact factor: 12.701

Review 8.  Cell surface molecules and tumor metastasis. Regulation of metastatic phenotypic diversity.

Authors:  G L Nicolson
Journal:  Exp Cell Res       Date:  1984-01       Impact factor: 3.905

9.  Identification of human immunodeficiency virus sequences by using in vitro enzymatic amplification and oligomer cleavage detection.

Authors:  S Kwok; D H Mack; K B Mullis; B Poiesz; G Ehrlich; D Blair; A Friedman-Kien; J J Sninsky
Journal:  J Virol       Date:  1987-05       Impact factor: 5.103

10.  Primer-dependent amplification of mdr1 mRNA by polymerase chain reaction.

Authors:  I Sugawara; M Watanabe; A Masunaga; S Itoyama; K Ueda
Journal:  Jpn J Cancer Res       Date:  1992-02
View more
  11 in total

1.  Immunohistochemical detection of nm23/NDP kinase and cathepsin D in medullary carcinomas of the thyroid gland.

Authors:  R Holm; J Høie; O Kaalhus; J M Nesland
Journal:  Virchows Arch       Date:  1995       Impact factor: 4.064

Review 2.  Metastatic dormancy and progression in thyroid cancer: targeting cells in the metastatic frontier.

Authors:  Matthew D Ringel
Journal:  Thyroid       Date:  2011-04-10       Impact factor: 6.568

3.  NM23 protein in neoplastic and nonneoplastic thyroid tissues.

Authors:  P Bertheau; A De La Rosa; P S Steeg; M J Merino
Journal:  Am J Pathol       Date:  1994-07       Impact factor: 4.307

4.  Immunohistochemical analysis of nm23 protein expression in malignant bone tumors.

Authors:  Y Oda; H Walter; K Radig; I Röse; W Neumann; A Roessner
Journal:  J Cancer Res Clin Oncol       Date:  1995       Impact factor: 4.553

5.  Expression of nm23-H1 gene product in thyroid, ovary, and breast cancers.

Authors:  T Okubo; S Inokuma; S Takeda; S Itoyama; K Kinoshita; I Sugawara
Journal:  Cell Biophys       Date:  1995-06

6.  Overexpression of nm23-H1 and nm23-H2 genes in colorectal carcinomas and loss of nm23-H1 expression in advanced tumour stages.

Authors:  J A Martinez; S Prevot; B Nordlinger; T M Nguyen; Y Lacarriere; A Munier; I Lascu; J C Vaillant; J Capeau; M L Lacombe
Journal:  Gut       Date:  1995-11       Impact factor: 23.059

7.  NDPKA is not just a metastasis suppressor - be aware of its metastasis-promoting role in neuroblastoma.

Authors:  Choon-Yee Tan; Christina L Chang
Journal:  Lab Invest       Date:  2017-10-09       Impact factor: 5.662

Review 8.  Metastatic mechanisms in follicular cell-derived thyroid cancer.

Authors:  John E Phay; Matthew D Ringel
Journal:  Endocr Relat Cancer       Date:  2013-10-14       Impact factor: 5.678

Review 9.  Molecular biology of breast cancer metastasis. Genetic regulation of human breast carcinoma metastasis.

Authors:  D R Welch; P S Steeg; C W Rinker-Schaeffer
Journal:  Breast Cancer Res       Date:  2000-07-21       Impact factor: 6.466

10.  Potential prognostic value in human breast cancer of cytosolic Nme1 protein detection using an original hen specific antibody.

Authors:  C Toulas; J Mihura; C de Balincourt; B Marques; E Marek; G Soula; H Roche; G Favre
Journal:  Br J Cancer       Date:  1996-03       Impact factor: 7.640

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.